Google
Trusted Resources: News & Events
Latest announcements and gatherings
Patients frequently turning to cannabis to treat symptoms of sickle cell disease
Medical cannabis use is relatively common among patients with sickle cell disease, according to survey data published in the journal Cannabis and Cannabinoid Research.
Investigators at Yale University conducted an anonymous questionnaire among 58 patients with the disease. Forty-two percent of respondents reported having used cannabis within the past two years, and 31 percent reported having used it within the past month.
Most respondents said that they did so for therapeutic purposes. Common symptoms of sickle cell disease include pain, fatigue, and swelling of the hands and feet.
Many respondents acknowledged that the use of cannabis “allowed for less use of pain medications” – a finding that is consistent with reports from other cohorts of chronic pain patients.
To date, the use of medicinal cannabis has not been evaluated in controlled settings for patients with sickle cell disease.
+myBinderRelated Content
-
Researchers raise funds for phase 1 trial to test medical cannabis in sickle cell diseaseThe Sickle Cell Foundation of Georgia ...
-
Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activ...Sickle cell anemia is a manifestation of...
-
The use of cannabis by patients with sickle cell disease increased the frequency of hospitalization due to vaso-occl...Introduction: The objective of this stu...
-
Marijuana use common in sickle cell patients, highlighting need for more research, study showsMany sickle cell disease (SCD)...
-
Public Meeting on Patient-Focused Drug Development for Chronic PainMeeting Information: On July 9, 2018, F...
-
Sickle Cell Patients are Innocent Victims of the Opioid Epidemic: Samir K. Ballas, MDhttps://www.youtube.com/watch?v=BOhY_gJo...
-
Long-term opioids may not be best pain management option for all sickle cell patientsSmall study shows some on opioids report...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.